Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

NCT06841510 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1118

Last updated 2025-09-16

No results posted yet for this study

Summary

Efficacy and Safety of GENOSS SES in patients with coronary artery disease

Conditions

  • Coronary Arterial Disease (CAD)

Sponsors & Collaborators

  • Genoss Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-19
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06841510 on ClinicalTrials.gov